Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Low-dose spironolactone effectively treats female pattern hair loss with mild side effects.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Finasteride reduces hair growth better, but spironolactone has more side effects.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Isoalantolactone promotes hair growth by activating specific cell pathways.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Stopping valproate and using lactulose can quickly treat valproate-induced hyperammonemia.

The guinea pig α-lactalbumin gene was successfully expressed in the mammary glands of transgenic mice.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Targeting the PGD2-DP2 pathway may help treat hair loss.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Abrocitinib may effectively treat Lichen Planopilaris.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Girard's reagent P improves detection of spironolactone and its metabolites.

Spironolactone might lower the chance of getting rosacea.

Combining progesterone with caffeine worsens breathing issues in newborns.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.